Ireland's Minister for Enterprise, Trade and Employment, Michael Martin has told assembled drug industry representatives at the Irish Pharmaceutical Healthcare Association's annual meeting that the sector would "have to move up the value chain" if the country is to attract R&D investment. Mr Martin also told his audience that the Irish government, for its part, is refining the R&D tax credit.
IPHA president John McLaughlin noted that 14 of the world's top 15 research-based drugmakers have established manufacturing facilities in Ireland in the past 20 years. He added that Ireland is the largest net exporter of drugs in the world.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze